Litcius/Paper detail

Depot buprenorphine during COVID-19 in Australia: Opportunities and challenges

Shalini Arunogiri, Nicholas Lintzeris

2020Journal of Substance Abuse Treatment21 citationsDOIOpen Access PDF

Topics & Concepts

BuprenorphineCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BetacoronavirusPandemicCoronavirus InfectionsMedicineVirologyMEDLINEPsychiatryPolitical scienceOpioidInternal medicineLawOutbreakInfectious disease (medical specialty)DiseaseReceptorOpioid Use Disorder TreatmentPrenatal Substance Exposure EffectsCardiac Arrest and Resuscitation
Depot buprenorphine during COVID-19 in Australia: Opportunities and challenges | Litcius